IL6 and arthritic joint disease: Surprisingly, anti-IL-6 treatment on day 8 resulted in improvement in the clinical index (Figure 3e), although treatment on day 14 had no effect on the course of the disease (data not shown), suggesting that IL-6 is also pathologically crucial in the early effector phase in arthritis.